H11.069
Recurrent pterygium of unspecified eye
Clinical Classification Guidelines
Medical Intelligence & Overview
Recurrent pterygium is a condition characterized by the growth of a wing-shaped tissue on the conjunctiva that extends onto the cornea of the eye after previous treatment or occurrence. When the condition recurs without specific details of the affected eye, it is classified under ICD-10 code H11.069. This condition can affect vision and eye comfort, often necessitating medical attention to manage symptoms and prevent progression.
Causes & Symptoms
Clinical Causes: Previous pterygium surgery that failed to completely remove the tissue Prolonged exposure to sunlight, UV rays, and environmental irritants Chronic eye irritation from dust, wind, or smoke Genetic predisposition or family history Environmental factors like dry or dusty conditions
Key Symptoms: Growth of tissue on the conjunctiva extending onto the cornea Redness and inflammation in the affected eye A feeling of foreign body sensation or irritation in the eye Tearing or watery eyes Blurred vision if the growth encroaches on the cornea Cosmetic concerns due to visible tissue growth
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an ophthalmologist. The healthcare provider will assess the growth's size, location, and extent, often using slit-lamp biomicroscopy to get a detailed view of the tissue. Medical history, including previous pterygium treatments, and visual acuity tests may also be performed to evaluate any impact on vision.
Treatment Protocols: Management of recurrent pterygium may include a variety of options, depending on the severity and progression. These include: - Observation for minor cases without significant symptoms - Medical management with lubricating eye drops or anti-inflammatory medications to reduce irritation and inflammation - Surgical removal of the pterygium if it causes discomfort, vision impairment, or cosmetic concerns - Postoperative measures such as eye patches or medications to minimize the risk of recurrence - Use of adjunct therapies like conjunctival autografts or mitomycin C during surgery to decrease recurrence rates It is important to seek professional consultation for tailored treatment options and follow-up care.
Clinical Advice & FAQs
Billing Guidance
Is H11.069 a billable ICD-10 code?
Yes, H11.069 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H11.069?
Clinical documentation must specify the nature of Recurrent pterygium of unspecified eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference